NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹8.97 Cr | ₹28 Cr | ₹91 Cr | ₹75 Cr | ₹105 Cr |
What is the latest Contingent Liabilities ratio of NEULAND LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹8.97 Cr |
Mar2024 | ₹28 Cr |
Mar2023 | ₹91 Cr |
Mar2022 | ₹75 Cr |
Mar2021 | ₹105 Cr |
How is Contingent Liabilities of NEULAND LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹8.97 Cr | -67.65 | |
Mar2024 | ₹28 Cr | -69.60 | |
Mar2023 | ₹91 Cr | 22.14 | |
Mar2022 | ₹75 Cr | -28.68 | |
Mar2021 | ₹105 Cr | - |
Compare Contingent Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹19,582.6 Cr | 27.8% | 19.2% | 80.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 27.8% |
19.2% |
80.3% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses